Riverine Ventures
Overview
Riverine Ventures is a venture capital firm that provides capital and guidance to entrepreneurs building solutions for life science and healthcare companies. The firm focuses on investing in early-stage private companies working on breakthrough biomedical technologies, including therapeutics, devices, diagnostics, and data-driven insights that address unmet medical needs. Their investment sectors include High Tech, Life Sciences, Enterprise Applications, and HealthTech.
Portfolio Companies
3
Website
riverine.venturesInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Genomenon Inc. | Mar 2022 | Series B | Co-investor |
| CellFE | Sep 2023 | Series A | Co-investor |
| Mediphage Bioceuticals | Feb 2024 | Seed | Co-investor |
Key People
Neil Littman
Venture Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Riverine Ventures based?
Riverine Ventures is headquartered in Sausalito, California, United States.
When was Riverine Ventures founded?
Founding year information for Riverine Ventures is not publicly available.
How many portfolio companies does Riverine Ventures have?
Riverine Ventures has 3 portfolio companies in Caplight's dataset.
What are some companies in Riverine Ventures's portfolio?
Portfolio companies visible on Caplight include Genomenon Inc., CellFE, Mediphage Bioceuticals.
What was Riverine Ventures's most recent investment shown here?
Riverine Ventures's most recent investment in this portfolio sample was in Mediphage Bioceuticals in 2024.
What sectors does Riverine Ventures focus on?
Riverine Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software.
What company stages does Riverine Ventures focus on?
Riverine Ventures typically invests at the Early stage.